KathleenColleranMD(She/Her)

PubMed

• 18 citations
  Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects.
  Amisha Wallia, Kathleen Colleran, Jonathan Q. Purnell, Coleman Gross, Mark E. Molitch
  Diabetes Care. 2013-09-01
• 302 citations
  Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care.
  Sanjeev Arora, Summers Kalishman, Karla Thornton, Denise Dion, Glen H. Murata
  Hepatology. 2010-09-01
• 54 citations
  Thiazolidinediones: A Comparative Review of Approved Uses
  Vidushi Sood, Kathleen Colleran, Mark R. Burge
  Diabetes Technology & Therapeutics. 2000-01-01

Journal Articles

• Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome: Early and Late Effects  
  Wallia A, Colleran KM, Purnell J, Gross C, Molitch M, Diabetes Care, 1/1/2013
• Building Capacity to Reduce Disparities in Diabetes: Training Community Health Workers Using an Integrated Distance Learning Model  
  Colleran K, Harding E Kipp B, Zurawski A, MacMillan B, Jelinkova L, Kalishman S, Dion D, Som D, and Arora S, The Diabetes Educator, 1/1/2012
• Carvedilol vs Metoprolol: A comparison of effects on endothelial function and oxidative stress in response to acute hyperglycemia in patients with type 2 diabetes and ...  
  Colleran K, Aguirre L, Burge MR, Journal of Diabetes Mellitus, 1/1/2012
• Quality Profile: Partnering Urban Academic Medical Centers and Rural Primary Care Clinicians to Provide Complex Chronic Disease Care  
  Arora S, Kalishman S, Dion D, Som D, Thornton K, Bankhurst A, Boyle J, Harkins M, Moseley K, Murata G, Komaramy M, Katzman J, Colleran K, Deming P, Yutzy S, Health Affairs, 1/1/2011
• Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care  
  Arora S, Kalishman S, Thornton K, Dion D, Murata G, Deming P, Parish B, Brown J, Komaromy M, Colleran K, Bankhurst A, Katzman J, Harkins M, Curet L, Cosgrove E, Pak W, Hepatology, 1/1/2010
• Disparities in cardiovascular disease risk and treatment: demographic comparison  
  Colleran KM, Richards A, Shafer K, J Investig Med, 1/1/2008
• Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Preventi...  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes, 1/1/2007
• The Development of Diabetes Self-Management Patient Education: Achieving Glycemic Control - from referral to collaboration  
  Colleran KM, Stanfield S, Nipper M, Review of Endocrinology, 1/1/2007
• The incidence of serologic evidence of antecedent autoimmune thyroiditis in asymptomatic patients referred to an outpatient rheumatology consultation clinic for positi...  
  Twining JM, Sibbitt W, Torres-Draeger H, Colleran, K, Bankhurst AD, Clinical and Experimental Rheumatology, 1/1/2007
• Body size and shape changes and the risk of diabetes in the Diabetes Prevention Program (DPP)  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes, 1/1/2007
• Factors associatd with diabetes onset during metformin versus placebo therapy in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes, 1/1/2007
• The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetic Medicine, 1/1/2007
• Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone  
  The Diabetes Prevention Program Research Group, including Colleran K, J Clin Endocrinol Metab, 1/1/2007
• Psychological predictors of physical activity in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, J Am Diet Assoc, 1/1/2006
• Relationship of body size and shape to the development of diabetes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Obesity, 1/1/2006
• TCF7L2 Polymorphisms and progression to diabetes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, NEJM, 1/1/2006
• Physical activity in individuals at risk for diabetes: Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Medicine & Science in Sports and Exercise, 1/1/2006
• Physical activity in individuals at risk for diabetes: Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Med Sci Sports Exerc, 1/1/2006
• The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes  
  The Diabetes Prevention Program Research Group, including Colleran K, Journal of Gerontology, 1/1/2006
• The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• The association among autonomic nervous system function incident diabetes and intervention arm in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Lifestyle intervention is associated with lower prevalence of urinary incontinence: The Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Effect of weight loss with lifestyle intervention on risk of diabetes  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• An update on the diabetes prevention program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Join now to see all

Books/Book Chapters

• Emergencies in Diabetes. 
  Chapter: Hypoglycaemia Caused by Insulin Secretagogues 
  Page 95 - 111Colleran, K, Krentz A, and Burge, MEditors: AJ Krentz.John Wiley & Sons Ltd2004
• The NORD Guide to Rare Disorders. 
  Chapter: Primary Empty Sella Syndrome 
  Colleran KLippincott, Williams & Wilkins, Philadelphia, PA2003

Abstracts/Posters

• Digital retinal imaging: community Health Workers as Imagers in Rural Areas versus an Ophthamology clinic.
  Colleran K, et al, European Association for the Study of Diabetes, Barcelona, Spain, 1/1/2013
• Assessing physician's attitudes toward community health care workers as members of the diabetes care team.
  Jones, B, Iwamoto T, and Colleran, K, Western Medical Student, Resident and Fellow Research Conference, Carmel, CA, 1/25/2012
• Effectiveness of standardization of community healthcare workers with training programs.
  Iwamoto, T and Colleran, K, Western Medical Student, Resident and Fellow Research Conference, Carmel, CA, 1/25/2012
• Retinal Screening Using CHWs in Rural and Underserved Communities of New Mexico: An Innovative Public/Private Collaboration
  Colleran K et al, APHA 100th Annual meeting, San Francisco, CA, 1/1/2012
• Project ECHOs innovative CHWs training Initiatives: Outcomes Integration and Impact.
  Colleran K et al, APHA 100th Annual meeting, San Francisco, CA, 1/1/2012
• An innovative community health worker training program: addressing the diabetes pandemic through expansion of the diabetes health care team.
  Colleran K, Harding E, Zurawski A, Som D, Kipp B, European Association for the Study of Diabetes, Berlin, Russia, 1/1/2012
• Building capacity to reduce diabetes disparities: training community health workers.
  Bouchonville, M, Colleran, K, and Kipp, B, Western Medical Student, Resident and Fellow Research Conference, Carmel, CA, 1/26/2011
• Effects of intermittent hypoxia on blood pressure and glucose metabolism in male Sprague Dawley rats
  L. Aguirre MD, Xavier De Leon MD, Karen Swezea MD, Benjamin Walker MD, Kathleen Colleran MD, and Nancy Kanagy PhD., NIH NIDDK network of Minority Research Investigators (NMRI)-national meeting, Bethesda, MD, 1/22/2010
• Effects of intermittent hypoxia on blood pressure, serum plasminogen activator 1 and glucose metabolism in male Sprague Dawley rats.
  LE Aguirre MD, X DeLeon BS, KL Sweazea PhD, BR Walker PhD, KM Colleran MD and NL Kanagy PhD, Endocrine Reviews; Endocrine Society, 1/1/2010
• Aggressive Pheochromocytoma: A Rare Presentation a Rare Disease Secondary to a Rare Genetic Disorder. Is there a Place for Innovative Medical Therapies?
  Podolsky, D and Colleran, K, Journal of Investigative Medicine, 1/1/2008
• A telemedicine Model Improves Attitudes to Diabetes in Medical Students Participating in a Rural Medicine Rotation in New Mexico.
  Sawyer, A, Colleran, K, Journal of Investigative Medicine, 1/1/2008
• Hemochromotosis Induced diabetes. Is phlebotomy curative or falsely reassuring?
  Bouchonville, M Colleran, K, Regional American College of Physicians, 1/1/2007
• Ethnic based Differences in PAI-1 Activity and Regulation
  Barchie, Panja, Colleran, Endocrine Society, 1/1/2007
• A pilot study investigating the association between mindful eating and living (MEAL), weight loss, and biologic markers of inflammation and metabolism in obese subjects.
  Sloan Al, Colleran KM, Shelley B, Journal of Investigative Medicine, 1/1/2007
• Increasing Quartiles of Obesity Preferentially Alter Proatherogenic Adipocytokines
  Colleran K, Panja S, and Barchie, M, J Invest Med, 1/1/2006
• Absent Uterus and Ovaries Misdiagnosed as Delayed Puberty in a Patient with Fanconi's Anemia.
  Sloan A, Colleran K, Journal of Investigative Medicine, Carmel, CA, 1/1/2006
• Increasing Quartiles of Obesity Preferentially Alter Proatherogenic Adipocytokines.
  Colleran K, Panja S, and Barchie, M, Annual Meeting at the Endocrine Society, Boston, MA, 1/1/2006
• Increasing Quartiles of Obesity Preferentially Alter Proatherogenic Adipocytokines.
  Colleran K, Panja S, Barchie M, Endocrine Society, Boston, MA, 1/1/2006
• Reification of Abstract Concepts to Improve Comprehension Using Interactive Virtual Environments and a Knowledge-Based Design.
  Alverson DC, Saiki Jr. SM, Caudell TP, Stevens S, Saland L, Colleran K, Brandt J, Danielson L, Cerilli L, Harris A, Gregory MC, Stewart R, Norenberg J, Shuster G, Pana..., International Association of Medical Science Educators 9th Annual Meeting, Los Angeles, CA, 1/1/2005
• The effect of meal composition on cardiovascular markers in patients with diabetes mellitus.
  Panja S Barchie M and Colleran, K, J Invest Med, 1/1/2005
• The effect of meal composition on adipocyte derived markers of cardiovascular disease in type 2 diabetes: Role of ethnicity?
  Panja S, Barchie M, Colleran K, Diabetes, 1/1/2005
• Low Density Lipoprotein Lowering Efficacy of the Ezetimibe/Simvastatin Combination Tablet in a Large Cohort of Women
  Gallup E, Colleran K et al, Second International Conference on Women Heart Disease and Stroke, Orlando, FL, 1/1/2005
• Disparities In Cardiovascular Disease Risks and Treatment: A Comparison Of Hispanic And Non-Hispanic Whites
  Shafer K, Richardson A, Skipper B, Colleran K, J Invest Med, 1/1/2005
• Comparative self-Reported Quality of Life among Obese Hispanics and non-Hispanic Whites
  Barchie M, Panja S, and Colleran K, J Invest Med, 1/1/2005
• A Unique Case of Cabergoline Resistant Prolactinoma.
  Nagaraja N and Colleran K, J Invest Med, 1/1/2005
• Join now to see all

Lectures

• Common Thyroid Dilemnas 
  1/1/2015
• An update on Type 1 Diabetes. 
  1/1/2014
• Pediatric Obesity Update 
  1/1/2013
• Pediatric Obesity 
  UNMHSC - 1/1/2012
• Expanding the Diabetes Health Care Team for Chronic Disease the Role of Community Health Workers 
  Taos, NM, 2011; UNMHSC, 2011 - 1/1/2011
• Diabetes Best Practices 
  Albuquerque, NM - 1/1/2009
• Impending Health Care Crisis as it Relates to Diabetes: Problems and Solutions 
  Albuquerque, NM - 1/1/2009
• Cardiovascular Disease and Diabetes: How they affect each other. 
  Las Clinicas Del Norte, El Rito, NM - 1/1/2009
• Diabetes Update 
  Multiple Locations, 2007, 2008, 2009 - 1/1/2009
• Community Health Workers. 
  Albuquerque, NM - 1/1/2008
• Lipid Update. 
  1/1/2008
• Obesity Then and Now. When will it End. 
  Multiple Locations, 2007, 2008 - 1/1/2008
• A look at the Data. 
  Albuquerque, NM - 1/1/2008
• Closing the Knowledge Gap for Community Health Workers. 
  Albuquerque, NM - 1/1/2008
• Approaches to Treating Obesity in the Current Epidemic. 
  Albuquerque, NM - 1/1/2008
• Update of Lipid Disorders and Treatment 
  Santa Fe, NM, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007 - 1/1/2007
• Diabetes What's New and What's changing 
  1/1/2005
• Cardiovascular Risk Factors in Patients with Type 2 diabetes. New Directions 
  1/1/2004
• Dysmetabolic Syndrome: Why Should We Care? 
  1/1/2003
• Race Risk and Cardiovascular Disease 
  1/1/2003
• Therapeutic Options in Type 2 DM 
  1/1/2002
• Diabetes, Hope and Micro-Hope trials. 
  University of New Mexico - 1/1/2001
• Hyperthyroidism 
  Santa Fe, NM - 1/1/2000
• Osteoporosis Diagnosis and Treatments 
  Taos, NM - 1/1/2000
• Women and Cardiovascular Disease 
  Santa Fe, NM - 1/1/2000
• Join now to see all